Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06381076 · ClinicalTrials.gov registry record · Phase 3
High-protein Oral Supplement With Liposomal Curcumin in Adults Undergoing Hemodialysis.
A Phase 3 study of Chronic Kidney Disease 5D, sponsored by University of Florida.
- Completed
- Registry status
- Phase 3
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT06381076 is a Phase 3 study of Chronic Kidney Disease 5D that has completed, run by University of Florida. The registered enrollment target is 35 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06381076, a Phase 3 study of Chronic Kidney Disease 5D, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
A 12-week double-blind randomized control trial will be conducted among adults on hemodialysis (n=15) to determine the impact of liposomal curcumin in a high-protein product on inflammation markers and oxidative stress. Participants will be randomized via a computer-generator into either the control or intervention group. Participants in each group will be given a total of 38 g of a high protein product with or without 7 mls of liposomal curcumin for a total of 8 weeks. At baseline, weeks 8 and 12, participants will have blood sampled and complete a 3-day 24-hour recalls (2 non-dialysis days and 1 dialysis day) and a quality of life survey.
Conditions Studied
Interventions
- DRUG Liposomal curcumin
- DRUG Food colorant
Study Locations (1)
Florida
- University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2025-02-03 |
| Est. Completion | 2025-05-13 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06381076
The ClinicalTrials.gov registry entry for NCT06381076 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Kidney Disease 5D appearing as the primary indexed condition, and to 2 interventions - of which Liposomal curcumin is the first listed.
NCT06381076 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT06381076 about?
NCT06381076 is a clinical study titled "High-protein Oral Supplement With Liposomal Curcumin in Adults Undergoing Hemodialysis.". A 12-week double-blind randomized control trial will be conducted among adults on hemodialysis (n=15) to determine the impact of liposomal curcumin in a high-protein product on inflammation markers and oxidative stress. Participants will be randomized via a computer-generator into either the control...
What is the current status of trial NCT06381076?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 35 participants. The study started on 2025-02-03. Estimated completion is 2025-05-13.
What conditions does trial NCT06381076 study?
This clinical trial studies the following conditions: Chronic Kidney Disease 5D.
What interventions are being tested in trial NCT06381076?
The interventions under investigation include: Liposomal curcumin (DRUG), Food colorant (DRUG).
Who is sponsoring clinical trial NCT06381076?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06381076 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.